SelectQuote faces DOJ and class-action lawsuits over alleged deceptive Medicare Advantage sales practices, impacting stock prices and raising compliance concerns.
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
California regulators mandate closure of Meritage Health Plan due to solvency failures, prompting reassignment of 11,000 Medicare Advantage members by Oct. 31, 2025. Insurers must ensure continuity of care amid contract terminations.
UnitedHealth Group maintains strong 2026 Medicare Advantage Stars ratings and reaffirms 2025 earnings guidance, signaling stability amid market challenges.
Health Care Service Corporation expands its Medicare Advantage coverage to 30 states and DC, enhancing its national presence with diverse plan options for 2026.
SelectQuote under DOJ investigation for Medicare Advantage sales practices faces securities class-action lawsuit amid stock decline. Legal and regulatory insights.
UnitedHealth Group's stock price rises on stable Medicare Advantage ratings and 2025 earnings guidance despite regulatory scrutiny and mixed insider trading activity.
UnitedHealth expects 78% of members in Medicare Advantage plans rated four stars or higher for 2026, supporting government reimbursements and financial outlook amid cost pressures.
UnitedHealth plans to have most Medicare Advantage enrollees in four-star plans by 2026, while AI infrastructure deals influence technology and semiconductor markets, impacting health insurers and chipmakers alike.
Study reveals Medicare Advantage beneficiaries face longer hospital stays post-pandemic, driven by skilled nursing facility shortages and administrative barriers, impacting healthcare operations and costs.
